Form 4: Lemaitre Vascular Inc. Executive Acquires Shares Through Dividend Equivalent Rights

Lawrence J. Jasinski, an executive at Lemaitre Vascular Inc., acquired shares through the release of dividend equivalent rights.

Summary

• Lawrence J. Jasinski, an executive at Lemaitre Vascular Inc., acquired shares of common stock on December 9, 2024.
• The shares were acquired through the release of dividend equivalent rights.
• These rights were associated with a restricted stock unit award granted on December 8, 2023.
• The acquisition was on a one-for-one basis, meaning one share was received for each dividend equivalent right.
• A total of 1 share was acquired at a price of $3.0099 per share.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation transaction, which is generally viewed positively as it aligns executive interests with shareholder value. There are no negative implications.

Positives

• The acquisition of shares by an executive can be seen as a positive sign of confidence in the company's future.

Industry Context

This type of transaction is common in executive compensation packages, where restricted stock units and dividend equivalent rights are used to align executive interests with shareholder value.

Comparison to Industry Standards

• Many companies in the medical device industry use restricted stock units and dividend equivalent rights as part of their executive compensation packages.
• The one-for-one conversion of dividend equivalent rights to shares is a standard practice.
• The value of the shares acquired is consistent with the market price at the time of the transaction.

Stakeholder Impact

• The share acquisition has a minor positive impact on shareholders as it indicates executive confidence in the company.

Key Dates

Keywords

Lemaitre Vascular Inc., LMAT, Dividend Equivalent Rights, Share Acquisition, Restricted Stock Unit, Executive Compensation